Literature DB >> 26888286

Expression of factor H binding protein in meningococcal strains can vary at least 15-fold and is genetically determined.

Massimiliano Biagini1, Marco Spinsanti1, Gabriella De Angelis1, Sara Tomei1, Ilaria Ferlenghi1, Maria Scarselli1, Fabio Rigat1, Nicola Messuti1, Alessia Biolchi1, Alessandro Muzzi1, Giulia Anderloni1, Brunella Brunelli1, Elena Cartocci1, Francesca Buricchi1, Chiara Tani1, Maria Stella1, Monica Moschioni1, Elena Del Tordello1, Annalisa Colaprico1, Silvana Savino1, Marzia M Giuliani1, Isabel Delany1, Mariagrazia Pizza1, Paolo Costantino1, Nathalie Norais1, Rino Rappuoli2, Vega Masignani2.   

Abstract

Factor H binding protein (fHbp) is a lipoprotein of Neisseria meningitidis important for the survival of the bacterium in human blood and a component of two recently licensed vaccines against serogroup B meningococcus (MenB). Based on 866 different amino acid sequences this protein is divided into three variants or two families. Quantification of the protein is done by immunoassays such as ELISA or FACS that are susceptible to the sequence variation and expression level of the protein. Here, selected reaction monitoring mass spectrometry was used for the absolute quantification of fHbp in a large panel of strains representative of the population diversity of MenB. The analysis revealed that the level of fHbp expression can vary at least 15-fold and that variant 1 strains express significantly more protein than variant 2 or variant 3 strains. The susceptibility to complement-mediated killing correlated with the amount of protein expressed by the different meningococcal strains and this could be predicted from the nucleotide sequence of the promoter region. Finally, the absolute quantification allowed the calculation of the number of fHbp molecules per cell and to propose a mechanistic model of the engagement of C1q, the recognition component of the complement cascade.

Entities:  

Keywords:  MenB vaccine; SRM-MS; antigen density; fHbp antigen; selected reaction monitoring mass spectrometry

Mesh:

Substances:

Year:  2016        PMID: 26888286      PMCID: PMC4791009          DOI: 10.1073/pnas.1521142113

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  33 in total

1.  The crystal structure of the globular head of complement protein C1q provides a basis for its versatile recognition properties.

Authors:  Christine Gaboriaud; Jordi Juanhuix; Arnaud Gruez; Monique Lacroix; Claudine Darnault; David Pignol; Denis Verger; Juan C Fontecilla-Camps; Gérard J Arlaud
Journal:  J Biol Chem       Date:  2003-09-05       Impact factor: 5.157

Review 2.  Structure and activation of the C1 complex of complement: unraveling the puzzle.

Authors:  Christine Gaboriaud; Nicole M Thielens; Lynn A Gregory; Véronique Rossi; Juan C Fontecilla-Camps; Gérard J Arlaud
Journal:  Trends Immunol       Date:  2004-07       Impact factor: 16.687

Review 3.  Complement activation, regulation, and molecular basis for complement-related diseases.

Authors:  Goran Bajic; Søren E Degn; Steffen Thiel; Gregers R Andersen
Journal:  EMBO J       Date:  2015-10-21       Impact factor: 11.598

4.  A universal vaccine for serogroup B meningococcus.

Authors:  Marzia M Giuliani; Jeannette Adu-Bobie; Maurizio Comanducci; Beatrice Aricò; Silvana Savino; Laura Santini; Brunella Brunelli; Stefania Bambini; Alessia Biolchi; Barbara Capecchi; Elena Cartocci; Laura Ciucchi; Federica Di Marcello; Francesca Ferlicca; Barbara Galli; Enrico Luzzi; Vega Masignani; Davide Serruto; Daniele Veggi; Mario Contorni; Maurizio Morandi; Alessandro Bartalesi; Vanda Cinotti; Donatella Mannucci; Francesca Titta; Elisa Ovidi; Jo Anne Welsch; Dan Granoff; Rino Rappuoli; Mariagrazia Pizza
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-06       Impact factor: 11.205

5.  The meningococcal vaccine candidate GNA1870 binds the complement regulatory protein factor H and enhances serum resistance.

Authors:  Guillermo Madico; Jo Anne Welsch; Lisa A Lewis; Anne McNaughton; David H Perlman; Catherine E Costello; Jutamas Ngampasutadol; Ulrich Vogel; Dan M Granoff; Sanjay Ram
Journal:  J Immunol       Date:  2006-07-01       Impact factor: 5.422

6.  Vertical distribution and phylogenetic characterization of marine planktonic Archaea in the Santa Barbara Channel.

Authors:  R Massana; A E Murray; C M Preston; E F DeLong
Journal:  Appl Environ Microbiol       Date:  1997-01       Impact factor: 4.792

7.  Measurement of live bacteria by Nomarski interference microscopy and stereologic methods as tested with macroscopic rod-shaped models.

Authors:  W W Baldwin; P W Bankston
Journal:  Appl Environ Microbiol       Date:  1988-01       Impact factor: 4.792

Review 8.  Immunoglobulin G: functional sites.

Authors:  D R Burton
Journal:  Mol Immunol       Date:  1985-03       Impact factor: 4.407

9.  Fine antigenic specificity and cooperative bactericidal activity of monoclonal antibodies directed at the meningococcal vaccine candidate factor h-binding protein.

Authors:  Peter T Beernink; Jo Anne Welsch; Michal Bar-Lev; Oliver Koeberling; Maurizio Comanducci; Dan M Granoff
Journal:  Infect Immun       Date:  2008-06-30       Impact factor: 3.441

10.  Neisseria meningitidis recruits factor H using protein mimicry of host carbohydrates.

Authors:  Muriel C Schneider; Beverly E Prosser; Joseph J E Caesar; Elisabeth Kugelberg; Su Li; Qian Zhang; Sadik Quoraishi; Janet E Lovett; Janet E Deane; Robert B Sim; Pietro Roversi; Steven Johnson; Christoph M Tang; Susan M Lea
Journal:  Nature       Date:  2009-02-18       Impact factor: 49.962

View more
  30 in total

1.  Discordant Effects of Licensed Meningococcal Serogroup B Vaccination on Invasive Disease and Nasal Colonization in a Humanized Mouse Model.

Authors:  Carolyn M Buckwalter; Elissa G Currie; Raymond S W Tsang; Scott D Gray-Owen
Journal:  J Infect Dis       Date:  2017-05-15       Impact factor: 5.226

2.  Emergence of a new Neisseria meningitidis clonal complex 11 lineage 11.2 clade as an effective urogenital pathogen.

Authors:  Yih-Ling Tzeng; Jose A Bazan; Abigail Norris Turner; Xin Wang; Adam C Retchless; Timothy D Read; Evelyn Toh; David E Nelson; Carlos Del Rio; David S Stephens
Journal:  Proc Natl Acad Sci U S A       Date:  2017-04-03       Impact factor: 11.205

3.  Methods for Assessment of OMV/GMMA Quality and Stability.

Authors:  Francesca Micoli; Renzo Alfini; Carlo Giannelli
Journal:  Methods Mol Biol       Date:  2022

4.  Neisseria meningitidis Urethritis Outbreak Isolates Express a Novel Factor H Binding Protein Variant That Is a Potential Target of Group B-Directed Meningococcal (MenB) Vaccines.

Authors:  Yih-Ling Tzeng; Serena Giuntini; Zachary Berman; Soma Sannigrahi; Dan M Granoff; David S Stephens
Journal:  Infect Immun       Date:  2020-11-16       Impact factor: 3.441

5.  The role of apolipoprotein N-acyl transferase, Lnt, in the lipidation of factor H binding protein of Neisseria meningitidis strain MC58 and its potential as a drug target.

Authors:  R A G da Silva; C P Churchward; A V Karlyshev; O Eleftheriadou; A K Snabaitis; M R Longman; A Ryan; R Griffin
Journal:  Br J Pharmacol       Date:  2016-12-21       Impact factor: 8.739

6.  Genetic Diversity of Meningococcal Serogroup B Vaccine Antigens among Carriage Isolates Collected from Students at Three Universities in the United States, 2015-2016.

Authors:  Henju Marjuki; How-Yi Chang; Nadav Topaz; Melissa J Whaley; Jeni Vuong; Alexander Chen; Laurel T Jenkins; Fang Hu; Susanna Schmink; Adam C Retchless; Jennifer D Thomas; Anna M Acosta; Lucy A McNamara; Heidi M Soeters; Sarah Mbaeyi; Xin Wang
Journal:  mBio       Date:  2021-05-18       Impact factor: 7.867

Review 7.  Hijacking Complement Regulatory Proteins for Bacterial Immune Evasion.

Authors:  Elise S Hovingh; Bryan van den Broek; Ilse Jongerius
Journal:  Front Microbiol       Date:  2016-12-20       Impact factor: 5.640

Review 8.  Recent Progress in the Prevention of Serogroup B Meningococcal Disease.

Authors:  Ian M Feavers; Martin C J Maiden
Journal:  Clin Vaccine Immunol       Date:  2017-05-05

9.  Effect of complement Factor H on antibody repertoire and protection elicited by meningococcal capsular group B vaccines containing Factor H binding protein.

Authors:  Peter T Beernink
Journal:  Hum Vaccin Immunother       Date:  2019-10-22       Impact factor: 3.452

10.  Bioinformatic analysis of meningococcal Msf and Opc to inform vaccine antigen design.

Authors:  Clio A Andreae; Richard B Sessions; Mumtaz Virji; Darryl J Hill
Journal:  PLoS One       Date:  2018-03-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.